Literature DB >> 21962440

The roles of cyclic nucleotide phosphodiesterases (PDEs) in steroidogenesis.

Li-Chun Lisa Tsai1, Joseph A Beavo.   

Abstract

The second messenger, cAMP, is one of the most important regulatory signals for control of steroidogenesis. This review focuses on current knowledge about regulation of cyclic nucleotides by phosphodiesterases (PDEs) in steroidogenic tissues. The first PDE known to directly regulate steroidogenesis was PDE2, the cGMP-stimulated PDE. PDE2 mediates ANP/cGMP-induced decreases in aldosterone production. Recently, the PDE8 family has been shown to control steroidogenesis in two tissues. Specifically, PDE8A regulates testosterone production by itself and in concert with additional IBMX-sensitive PDEs. PDE8B modulates basal corticosterone synthesis via acute and chronic mechanisms. In addition to cAMP-dependent pathways, cGMP signaling also can promote steroidogenesis, and PDE5 modulates this process. Finally, PDE mutations may lead to several human diseases characterized by abnormal steroid levels.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21962440      PMCID: PMC4034742          DOI: 10.1016/j.coph.2011.09.003

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  42 in total

1.  Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia.

Authors:  Anelia Horvath; Veronica Mericq; Constantine A Stratakis
Journal:  N Engl J Med       Date:  2008-02-14       Impact factor: 91.245

Review 2.  The adrenal cortex and life.

Authors:  Gavin P Vinson
Journal:  Mol Cell Endocrinol       Date:  2008-09-17       Impact factor: 4.102

3.  Modulation of Leydig cell function by cyclic nucleotide phosphodiesterase 8A.

Authors:  Valeria Vasta; Masami Shimizu-Albergine; Joseph A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-15       Impact factor: 11.205

Review 4.  Regulating gene transcription in response to cyclic AMP elevation.

Authors:  William A Sands; Timothy M Palmer
Journal:  Cell Signal       Date:  2007-10-12       Impact factor: 4.315

Review 5.  Aldosterone and cardiovascular disease.

Authors:  Krishna K Gaddam; Eduardo Pimenta; Saima Husain; David A Calhoun
Journal:  Curr Probl Cardiol       Date:  2009-02       Impact factor: 5.200

6.  Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome.

Authors:  David P Macfarlane; Shareen Forbes; Brian R Walker
Journal:  J Endocrinol       Date:  2008-05       Impact factor: 4.286

7.  A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex.

Authors:  Anelia Horvath; Christoforos Giatzakis; Kitman Tsang; Elizabeth Greene; Paulo Osorio; Sosipatros Boikos; Rossella Libè; Yianna Patronas; Audrey Robinson-White; Elaine Remmers; Jerôme Bertherat; Maria Nesterova; Constantine A Stratakis
Journal:  Eur J Hum Genet       Date:  2008-04-23       Impact factor: 4.246

8.  Negative regulation of corticotropin releasing factor expression and limitation of stress response.

Authors:  Greti Aguilera; Alexander Kiss; Ying Liu; Anna Kamitakahara
Journal:  Stress       Date:  2007-06       Impact factor: 3.493

9.  cGMP-dependent protein kinase II and aldosterone secretion.

Authors:  Beate Spiessberger; Dominik Bernhard; Stefan Herrmann; Susanne Feil; Claudia Werner; Peter B Luppa; Franz Hofmann
Journal:  FEBS J       Date:  2008-01-13       Impact factor: 5.542

10.  Protein kinase G-mediated stimulation of basal Leydig cell steroidogenesis.

Authors:  Silvana A Andric; Marija M Janjic; Natasa J Stojkov; Tatjana S Kostic
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-09-11       Impact factor: 4.310

View more
  18 in total

Review 1.  Advances in targeting cyclic nucleotide phosphodiesterases.

Authors:  Donald H Maurice; Hengming Ke; Faiyaz Ahmad; Yousheng Wang; Jay Chung; Vincent C Manganiello
Journal:  Nat Rev Drug Discov       Date:  2014-04       Impact factor: 84.694

Review 2.  Phosphodiesterase 8B and cyclic AMP signaling in the adrenal cortex.

Authors:  Leticia Ferro Leal; Eva Szarek; Fabio Faucz; Constantine A Stratakis
Journal:  Endocrine       Date:  2015-05-14       Impact factor: 3.633

3.  SCAP/SREBP pathway is required for the full steroidogenic response to cyclic AMP.

Authors:  Masami Shimizu-Albergine; Brian Van Yserloo; Martin G Golkowski; Shao-En Ong; Joseph A Beavo; Karin E Bornfeldt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

4.  Illicit Upregulation of Serotonin Signaling Pathway in Adrenals of Patients With High Plasma or Intra-Adrenal ACTH Levels.

Authors:  Julie Le Mestre; Céline Duparc; Yves Reznik; Fidéline Bonnet-Serrano; Philippe Touraine; Olivier Chabre; Jacques Young; Mari Suzuki; Mathilde Sibony; Françoise Gobet; Constantine A Stratakis; Gérald Raverot; Jérôme Bertherat; Hervé Lefebvre; Estelle Louiset
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

5.  Aging has the opposite effect on cAMP and cGMP circadian variations in rat Leydig cells.

Authors:  Aleksandar Z Baburski; Srdjan J Sokanovic; Silvana A Andric; Tatjana S Kostic
Journal:  J Comp Physiol B       Date:  2016-12-03       Impact factor: 2.200

Review 6.  Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.

Authors:  F Ahmad; T Murata; K Shimizu; E Degerman; D Maurice; V Manganiello
Journal:  Oral Dis       Date:  2014-09-12       Impact factor: 3.511

7.  Multiple cAMP Phosphodiesterases Act Together to Prevent Premature Oocyte Meiosis and Ovulation.

Authors:  Giulia Vigone; Leia C Shuhaibar; Jeremy R Egbert; Tracy F Uliasz; Matthew A Movsesian; Laurinda A Jaffe
Journal:  Endocrinology       Date:  2018-05-01       Impact factor: 4.736

8.  Antenatal glucocorticoid exposure enhances the inhibition of adrenal steroidogenesis by leptin in a sex-specific fashion.

Authors:  Yixin Su; Luke C Carey; James C Rose; Victor M Pulgar
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-04-30       Impact factor: 4.310

9.  Calcineurin regulates homologous desensitization of natriuretic peptide receptor-A and inhibits ANP-induced testosterone production in MA-10 cells.

Authors:  Michelle B Henesy; Andrea L Britain; Bing Zhu; Lauren Amable; Richard E Honkanen; Jackie D Corbin; Sharron H Francis; Thomas C Rich
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

Review 10.  Glucocorticoid-induced osteoporosis in children with 21-hydroxylase deficiency.

Authors:  Annamaria Ventura; Giacomina Brunetti; Silvia Colucci; Angela Oranger; Filomena Ladisa; Luciano Cavallo; Maria Grano; Maria Felicia Faienza
Journal:  Biomed Res Int       Date:  2013-01-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.